Intrapartum GBS screening and antibiotic prophylaxis: a European consensus conference

References

• Centers for Disease Control and Prevention. Prevention of perinatal Group B streptococcal disease. MMWR 2002;51:1–22
   Google Scholar
• Melin P, Verschraegen G, Mahieu L, et al. Towards a Belgian consensus for prevention of perinatal group B streptococcal disease. Indian J Med Res 2004;119:197–200
   PubMed Web of Science ®Google Scholar
• Lopez Sastre JB, Fernandez Colomer B, Coto Cotallo GD, et al. Trends in the epidemiology of neonatal sepsis of vertical transmission in the era of group B streptococcal prevention. Acta Paediatr 2005;94:451–7
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Prevention of perinatal Group B streptococcal disease. Revised guidelines from CDC, 2010. MMWR 2010;59:No.RR-10:1–32
   Google Scholar
• Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 1976;294:753–6
   PubMed Web of Science ®Google Scholar
• Baker C. Group B streptococcal infections. In: Stevens DL, Kaplan EL, eds. Streptococcal infections. New York (NY): Oxford University Press; 2000:222–37
   Google Scholar
• Centers for Disease Control and Prevention. Perinatal group B streptococcal disease after universal screening recommendations United States 2003–2005. MMWR Morb Mortal Wkly Rep 2007;56:701–5
   Google Scholar
• Heath PT, Schuchat A. Perinatal group B streptococcal disease. Best Pract Res Clin Obstet Gynaecol 2007;21:411–24
   PubMed Web of Science ®Google Scholar
• Skoff TH, Farley MM, Petit S, et al. Increasing burden of invasive group B streptococcal disease in non pregnant adults, 1990–2007. CID 2009;49:85–92
   PubMed Web of Science ®Google Scholar
• Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000;342:15–20
   PubMed Web of Science ®Google Scholar
• Nizet V, Ferrieri P, Rubens CE. Molecular pathogenesis of group B streptococcal disease in newborns. In: Stevens DL, Kaplan EL, eds. Streptococcal infections. New York: Oxford University Press, 2000: 180–221
   Google Scholar
• Trijbels-Smeulders MAJM, Kolee LAA, Adriaanse AH, et al. Neonatal group B streptococcal infection: incidence and strategies for prevention in Europe. Pediatr Infect Dis J 2004;23:172–3
   PubMed Web of Science ®Google Scholar
• Edmond KE, Kortsalioudaki C, Scott S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet 2012;379:547–56
   PubMed Web of Science ®Google Scholar
• Melin P. Neonatal group B streptococcal disease: from pathogenesis to preventive strategies. Clin Microbiol Infect 2011;17:1294–303
   PubMed Web of Science ®Google Scholar
• Jordan HT, Farley MM, Craig A, et al. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J 2008;27:1057–64
   PubMed Web of Science ®Google Scholar
• Verani JR, Schrag SJ. Group B streptococcal disease in infants: progress in prevention and continued challenges. Clin Perinatol 2010;37:375–92
   PubMed Web of Science ®Google Scholar
• Anthony BF, Okada DM, Hobel CJ. Epidemiology of the group B streptococcus: maternal and nosocomial sources for infant acquisitions. J Pediatr 1979;95:431–6
   PubMed Web of Science ®Google Scholar
• Boyer KM, Gotoff SP. Prevention of early-onset neonatal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665–9
   PubMed Web of Science ®Google Scholar
• Dillon HC, Khare S, Gray BM. Group B streptococcal carriage and disease: a 6-year prospective study. J Pediatr 1987;110:31–6
   PubMed Web of Science ®Google Scholar
• Christensen KK, Dahlander K, Linden V, et al. Obstetrical care in future pregnancies after fetal loss in group B streptococcal septicemia. A prevention program based on bacteriological and immunological follow-up. Eur J Obstet Gynecol Reprod Biol 1981;12:143–50
   PubMedGoogle Scholar
• Carstensen H, Christensen KK, Grennert L, et al. Early-onset neonatal group B streptococcal septicaemia in siblings. J Infect 1988;17:201–4
   PubMedGoogle Scholar
• Faxelius G, Bremme K, Kvist-Christensen K, et al. Neonatal septicemia due to group B streptococci – perinatal risk factors and outcome of subsequent pregnancies. J Perinat Med 1988;16:423–30
   PubMedGoogle Scholar
• Flidel-Rimon O, Galstyan S, Juster-Reicher A, et al. Limitations of the risk factor based approach in early neonatal sepsis evaluations. Acta Paediatr 2012;101:e540–4
   PubMed Web of Science ®Google Scholar
• Heath PT, Balfour G, Weisner AM, et al.; PHLS Group B Streptococcus Working Group. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 2004;363:292–4
   PubMed Web of Science ®Google Scholar
• Håkansson S, Källén K, Bullarbo M, et al. Real-time PCR-assay in the delivery suite for determination of group B streptococcal colonization in a setting with risk-based antibiotic prophylaxis. J Matern Fetal Neonatal Med. 2014;27:328–32
   Google Scholar
• Easmon CS, Hastings MJ, Deeley J, et al. The effect of intrapartum chemoprophylaxis on the vertical transmission of group B streptococci. Br J Obstet Gynaecol 1983;90:633–5
   PubMedGoogle Scholar
• Yow MD, Mason EO, Leeds LJ, et al. Ampicillin prevents intrapartum transmission of group B streptococcus. JAMA 1979;241:1245–7
   PubMed Web of Science ®Google Scholar
• Tuppurainen N, Hallman M. Prevention of neonatal group B streptococcal disease: intrapartum detection and chemprophylaxis of heavily colonized parturients. Obstet Gynecol 1989;73:583–7
   PubMed Web of Science ®Google Scholar
• Royal College of Obstetricians and Gynecologsts. The prevention of early-onset neonatal group B streptococcal disease. Green-top Guideline No. 36. London: RCOG; 2012 [http://www.rcog.org.uk/womens-health/clinical-guidance/prevention-early-onset-neonatal-group-b-streptococcal-disease-green-]
   Google Scholar
• Håkansson S, Axemo P, Bremme K, et al; Swedish Working Group For The Prevention of Perinatal Group B Streptococcal Infections. Group B streptococcal carriage in Sweden: a national study on risk factors for mother and infant colonisation. Acta Obstet Gynecol Scand 2008;87:50–8
   PubMed Web of Science ®Google Scholar
• Steer PJ, Plumb J. Myth: Group B streptococcal infection in pregnancy: comprehended and conquered. Semin Fetal Neonatal Med 2011;16:254–8
   PubMedGoogle Scholar
• Akker-van Marle ME, Rijnders ME, Dommelen P, et al. Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early–onset group B streptococcal disease. BJOG 2005;112:820–6
   PubMedGoogle Scholar
• Schrag SJ, Zell ER, Lynfield R, et al.; Active Bacterial Core Surveillance Team. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002;347:233–9
   PubMed Web of Science ®Google Scholar
• Gilbert R. Prenatal screening for group B streptococcal infection: gaps in the evidence. Int J Epidemiol 2004;33:2–8
   PubMed Web of Science ®Google Scholar
• Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev 2013;1:CD007467
   PubMedGoogle Scholar
• Puopolo KM, Madoff LC, Eichenwald EC. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 2005;115:1240–6
   PubMed Web of Science ®Google Scholar
• Van Dyke MK, Phares CR, Lynfield R, et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 2009;360:2626–36
   PubMed Web of Science ®Google Scholar
• Pulver LS, Hopfenbeck MM, Young PC, et al. Continued early-onset group B streptococcal infections in the ear of intrapartum prophylaxis. J Perinatol 2009;29:20–5
   PubMed Web of Science ®Google Scholar
• Agence Nationale d’Accréditation et d’évaluation en Santé. Antenatal prevention of the risk of early neonatal bacterial infection: Clinical pratice guidelines. September 2001:1–10. Available from: http://www.has-sante.fr/portail/upload/docs/application/pdf/Antenatal_prevention.pdf [last accessed 14 Jan 2014]
   Google Scholar
• Superior Health Council. Guidelines from the Belgian Health Council, 2003 (SHC 7721): Prevention of perinatal group B streptococcal infections. Brussels, Belgium: Service Public Federal Sante publique, Securite de la Chaıne alimentaire et Environnement, 2003 (In English, in French, in Dutch)
   Google Scholar
• Alós Cortés JI, Andreu Domingo A, Arribas Mir L, et al. Prevention of Neonatal Group B Sreptococcal Infection. Spanish Recommendations. Update 2012. SEIMC/SEGO/SEN/SEQ/SEMFYC Consensus Document. Enferm Infecc Microbiol Clin 2013;31:159–72
   PubMedGoogle Scholar
• Stan CM, Boulvain M, Bovier PA, et al. Choosing a strategy to prevent neonatal early-onset group B streptococcal sepsis: economic evaluation. BJOG 2001;108:840–7
   PubMedGoogle Scholar
• Neonatal group B streptococcus infections in France: incidence from 1997 to 2006 and current prevention practices in maternity wards. Bulletin Epidémiologique Hebdomadaire 2008;14–15:110–13
   Google Scholar
• Stray-Pedersen B, Bergan T, Hafstad A. Vaginal disinfection with chlorhexidine during childbirth. Int J Antimicrob Agents 1999;12:245–51
   PubMed Web of Science ®Google Scholar
• Stade BC, Shah V, Ohlsson A. Vaginal chlorhexidine during labor to prevent early-onset neonatal group B streptococcal infection. Cochrane Database Syst Rev 2004;3:CD003520
   Google Scholar
• Cutland CL, Madhi SA, Zell ER, et al.; PoPS Trial Team. Chlorhexidine maternal-vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial. Lancet 2009;374:1909–16
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Piccinini F, Mordini B, Volpe A. Chlorhexidine vaginal flushings versus systemic ampicillin in the prevention of vertical transmission of neonatal group B streptococcus, at term. J Matern Fetal Neonatal Med 2002;11:84–8
   PubMedGoogle Scholar
• Goldenberg RL, McClure EM, Saleem S, et al. Use of vaginally administered chlorhexidine during labor to improve pregnancy outcomes. Obstet Gynecol 2006;107:1139–46
   PubMed Web of Science ®Google Scholar
• Poyart C, Reglier-Poupet H, Tazi A, et al. Invasive Group B streptococcal infections in infants, France. Emerg Infect Dis 2008;14:1647–9
   PubMedGoogle Scholar
• Manning SD, Springman AC, Lehotzky E, et al. Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada. J Clin Microbiol 2009;47:1143–8
   PubMed Web of Science ®Google Scholar
• Sorensen UB, Poulsen K, Ghezzo C, et al. Emergence and global dissemination of host-specific Streptococcus agalactiae clones. MBio 2010;1:1–9
   Google Scholar
• Bellais S, Six A, Fouet A, et al. Capsular switching in group B streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development. J Infect Dis 2012;206:1745–52
   PubMedGoogle Scholar
• Lamy MC, Dramsi S, Billoët A, et al. Rapid detection of the “highly virulent” group B Streptococcus ST-17 clone. Microbes Infect 2006;8:1714–22
   PubMedGoogle Scholar
• Lartigue MF, Kostrzewa M, Salloum M, et al. Rapid detection of “highly virulent” Group B Streptococcus ST-17 and emerging ST-1 clones by MALDI-TOF mass spectrometry. J Microbiol Methods 2011;86:262–5
   PubMed Web of Science ®Google Scholar
• Stoll BJ, Schuchat A. Maternal carriage of group B streptococci in developing countries. Pediatr Infect Dis J 1998;17:499–503
   PubMed Web of Science ®Google Scholar
• Bergeron MG, Menard C, et al. Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med 2000; 343:175–9
   PubMed Web of Science ®Google Scholar
• Dahesh S, Hensler ME, Van Sorge NM, et al. Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics. Antimicrob Agents Chemother 2008;52:2915–18
   PubMed Web of Science ®Google Scholar
• Kimura K, Suzuki S, Wachino J, et al. First molecular characterization of group B streptococci with reduced penicillin susceptibility. Antimicrob Agents Chemother 2008;52:2890–7
   PubMed Web of Science ®Google Scholar
• Melin P. Table 3O Resistance of Streptococcus agalactiae in Belgium. In: SBIMC-BVIKM ed. The Sanford guide to antimicrobial therapy, 23rd edition of the Belgian/Luxembourg Version 2012–2013. Brussels, Belgium: Societe Belge d’Infectiologie et de Microbiologie Clinique – Belgische Vereniging voor Infectiologie en Klinische Microbiologie; 2012:178–9
   Google Scholar
• Back EE, O’Grady EJ, Back JD. High rates of perinatal group B streptococcus clindamycin and erythromycin resistance in an upstate New York hospital. Antimicrob Agents Chemother 2012;56:739–42
   PubMed Web of Science ®Google Scholar
• Domelier AS, van der Mee-Marquet N, Arnault L, et al. Molecular characterization of erythromycin-resistant Streptococcus agalactiae strains. J Antimicrob Chemother 2008;62:1227–33
   PubMedGoogle Scholar
• Pinheiro S, Radhouani H, Coelho C, et al. Prevalence and mechanisms of erythromycin resistance in Streptococcus agalactiae from healthy pregnant women. Microb Drug Resist 2009;15:121–4
   PubMed Web of Science ®Google Scholar
• Bergseng H, Afset JE, Radtke A, et al. Molecular and phenotypic characterization of invasive group B streptococcus strains from infants in Norway 2006–2007. Clin Microbiol Infect 2009;12:1182–5 (Research note 1–4)
   Google Scholar
• Tazi A, Morand PC, Réglier-Poupet H, et al. Invasive group B streptococcal infections in adults, France (2007–2010). Clin Microbiol Infect 2011;17:1587–9
   PubMed Web of Science ®Google Scholar
• Imperi M, Gherardi G, Berardi A, et al. Invasive neonatal GBS infections from an area-based surveillance study in Italy. Clin Microbiol Infect 2011;17:1834–9
   Google Scholar
• de Azavedo JC, McGavin M, Duncan C, et al. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother 2001;45:3504–8
   PubMed Web of Science ®Google Scholar
• Desjardins M, Delgaty KL, Ramotar K, et al. Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results. J Clin Microbiol 2004;42:5620–3
   PubMed Web of Science ®Google Scholar
• Gygax SE, Schuyler JA, Kimmel LE, et al. Erythromycin and clindamycin resistance in group B streptococcal clinical isolates. Antimicrob Agents Chemother 2006;50:1875–7
   PubMed Web of Science ®Google Scholar
• Phares CR, Lynfield R, Farley MM, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999–2005. JAMA 2008;299:2056–65
   PubMed Web of Science ®Google Scholar
• Castor ML, Whitney CG, Como-Sabetti K, et al. Antibiotic resistance patterns in invasive group B streptococcal isolates. Infect Dis Obstet Gynecol 2008;2008:1–5
   Google Scholar
• Janapatla RP, Ho YR, Yan JJ, et al. The prevalence of erythromycin resistance in group B streptococcal isolates at a University Hospital in Taiwan. Microb Drug Resis 2008;14:293–7
   PubMedGoogle Scholar
• Seo YS, Srinivasan U, Oh KY, et al. Changing molecular epidemiology of group B streptococcus in Korea. J Korean Med Sci 2010;25:817–23
   PubMed Web of Science ®Google Scholar
• Granlund M, Axemo P, Bremme K, et al; Swedish Working Group for the Prevention of Perinatal Group B Streptococcal Infections. Antimicrobial resistance in colonizing group B Streptococci before the implementation of a Swedish intrapartum antibiotic prophylaxis program. Eur J Clin Microbiol Infect Dis 2010;29:1195–201
   PubMedGoogle Scholar
• Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 2002;34:482–92
   PubMed Web of Science ®Google Scholar
• The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 4.0, 2014. http://www.eucast.org
   Google Scholar
• Gilbert GL, Isaacs D, Burgess MA, et al. Prevention of neonatal group B streptococcal sepsis: is routine antenatal screening appropriate. Aust N Z J Obstet Gynaecol 1995;35:120–126
   PubMed Web of Science ®Google Scholar
• Yancey MK, Schuchat A, Brown LK, et al. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996;88:811–15
   PubMed Web of Science ®Google Scholar
• The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Screening and treatment for Group B streptococcus in pregnancy. College Statement C-Obs 19. 2009 [cited 2010 Feb 17]. Available from: www.ranzcog.edu.au/publications/statements/C-obs19.pdf
   Google Scholar
• Melin P, Schmitz M, Tsobo C, et al. Rapid intrapartum test (Strep B OIA) and prenatal cultures for identification of group B streptococcal carriers at delivery: a prospective study. In American Society of Microbiology (Ed.) Program and Abstracts of the 40th Intersciences Conference on Antimicrobial Agents and Chemotherapy 2000 (p145 No 357 session 30). Washington, USA: American Society for Microbiology (ASM). http://hdl.handle.net/2268/36477
   Google Scholar
• Davies HD, Miller MA, Faro S, et al. Multicenter study of a rapid molecular-based assay for the diagnosis of group B Streptococcus colonization in pregnant women. Clin Infect Dis 2004;39:1129–35
   PubMed Web of Science ®Google Scholar
• Valkenburg-van den Berg AW, Houtman-Roelofsen RL, Oostvogel PM, et al. Timing of group B streptococcus screening in pregnancy: a systematic review. Gynecol Obstet Invest 2010;69:174–83
   PubMed Web of Science ®Google Scholar
• El Helali N, Nguyen JC, Ly A, et al. Diagnostic accuracy of a rapid real-time polymerase chain reaction assay for universal intrapartum group B streptococcus screening. Clin Infect Dis 2009 Aug 1;49:417–23
   PubMed Web of Science ®Google Scholar
• Towers CV, Rumney PJ, Asrat T, et al. The accuracy of late third-trimester antenatal screening for group B streptococcus in predicting colonization at delivery. Am J Perinatol 2010;27:785–90
   PubMed Web of Science ®Google Scholar
• Church DL, Baxter H, Lloyd T, et al. Evaluation of the Xpert® group B streptococcus real-time polymerase chain reaction assay compared to StrepB Carrot Broth™ for the rapid intrapartum detection of group B streptococcus colonization. Diagn Microbiol Infect Dis 2011;69:460–2
   PubMed Web of Science ®Google Scholar
• de Tejada BM, Pfister RE, Renzi G, et al. Intrapartum Group B streptococcus detection by rapid polymerase chain reaction assay for the prevention of neonatal sepsis. Clin Microbiol Infect 2011;17:1786–91
   PubMed Web of Science ®Google Scholar
• Young BC, Dodge LE, Gupta M, et al. Evaluation of a rapid, real-time intrapartum group B streptococcus assay. Am J Obstet Gynecol 2011;205:372.e1–6
   PubMed Web of Science ®Google Scholar
• Lin FY, Weisman LE, Azimi P, et al. Assessment of intrapartum antibiotic prophylaxis for the prevention of early-onset group B Streptococcal disease. Pediatr Infect Dis J 2011;30:759–63
   PubMed Web of Science ®Google Scholar
• Badri MS, Zawaneh S, Cruz AC, et al. Rectal colonization with group B Streptococcus: relation to vaginal colonization of pregnant women. J Infect Dis 1977;135:308–12
   PubMed Web of Science ®Google Scholar
• Dillon HC, Gray E, Pass MA, Gray BM. Anorectal and vaginal carriage of group B streptococci during pregnancy. J Infect Dis 1982;145:794–9
   PubMed Web of Science ®Google Scholar
• Connelian M, Wallace EM. Prevention of perinatal group B streptococcal disease: screening practice in public hospitals in Victoria. MJA 2000;172:317–20
   PubMedGoogle Scholar
• Nys S, Vijgen S, Magerman K, Cartuyvels R. Comparison of Copan eSwab with the Copan Venturi Transystem for the quantitative survival of Escherichia coli, Streptococcus agalactiae and Candida albicans. Eur J Clin Microbiol Infect Dis 2010;29:453–6
   PubMedGoogle Scholar
• Melin P, Dodemont M, Sarlet G, et al. Improvement of transport condition of swabs for group B streptococcal screening. In American Society of Microbiology, Program and Abstracts of the 53rd Intersciences Conference on Antimicrobial Agents and Chemotherapy 2013 (poster D1662). Washington, USA: American Society for Microbiology (ASM)
   Google Scholar
• Philipson EH, Palermino DA, Robinson A. Enhanced antenatal detection of group B streptococcus colonization. Obstet Gynecol 1995;85:437–9
   PubMedGoogle Scholar
• Platt MW, McLaughlin JC, Gilson GJ, et al. Increased recovery of group B Streptococcus by the inclusion of rectal culturing and enrichment. Diagn Microbiol Infect Dis 1995;21:65–8
   PubMedGoogle Scholar
• Montague N, Cleary T, Martinez O, Procop G. Detection of group B streptococci in Lim broth by use of group B Streptococcus peptide nucleic acid fluorescent in situ hybridization and selective and nonselective agars. J Clin Microbiol 2008;46:3470–2
   PubMedGoogle Scholar
• Sociedad Española de Obstetricia y Ginecología. Sociedad Española de Neonatología. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Sociedad Española de Quimioterapia. Sociedad Española de Medicina Familiar y Comunitaria. 2003. Prevención de la infección perinatal por estreptococo del grupo B. Recomendaciones españolas revisadas. Enferm Infecc Microbiol Clin 2003;21:417–23
   PubMedGoogle Scholar
• El Helali N, Giovangrandi Y, Guyot K, et al. Cost and effectiveness of intrapartum group B streptococcus polymerase chain reaction screening for term deliveries. Obstet Gynecol 2012;119:822–9
   PubMed Web of Science ®Google Scholar
• Haberland CA, Benitz WE, Sanders GD, et al. Perinatal screening for group b streptococci: cost-benefit analysis of rapid polymerase chain reaction. Pediatrics 2002;110:471–80
   PubMed Web of Science ®Google Scholar
• Baker CJ. Inadequacy of rapid immunoassays for intrapartum detection of group B streptococcal carriers. Obstet Gynecol 1996;88:51–5
   PubMed Web of Science ®Google Scholar
• Picard FJ, Bergeron MG. Laboratory detection of group B Streptococcus for prevention of perinatal disease. Eur J Clin Microbiol Infect Dis 2004;23:665–71
   PubMed Web of Science ®Google Scholar
• Bergeron MG, Ke D, Ménard C, Picard FJ, et al. Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med 2000;343:175–9
   PubMed Web of Science ®Google Scholar
• Bergeron MG, Danbing K. New DNA-based PCR approaches for rapid real-time detection and prevention of group B streptococcal infections in newborns and pregnant women. Reprod Medi Rev 2004;11:I 25–41
   Google Scholar
• Aziz N, Baron EJ, D'Souza H, et al. Comparison of rapid intrapartum screening methods for group B streptococcal vaginal colonization. J Matern Fetal Neonatal Med 2005;18:225–9
   PubMed Web of Science ®Google Scholar
• Atkins KL, Atkinson RM, Shanks A, et al. Evaluation of polymerase chain reaction for group B streptococcus detection using an improved culture method. Obstet Gynecol 2006;108:488–91
   PubMed Web of Science ®Google Scholar
• Gavino M, Wang E. A comparison of a new rapid real-time polymerase chain reaction system to traditional culture in determining group B Streptococcus colonization. Am J Obstet Gynecol 2007;197:388 e1–4
   Google Scholar
• Edwards RK, Novak-Weekley SM, Koty PP, et al. Rapid group B streptococci screening using a real-time polymerase chain reaction assay. Obstet Gynecol 2008;111:1335–41
   PubMed Web of Science ®Google Scholar
• Money D, Dobson S, Cole L, et al. An evaluation of a rapid real time polymerase chain reaction assay for detection of group B streptococcus as part of a neonatal group B streptococcus prevention strategy. J Obstet Gynaecol Can 2008;30:770–5
   PubMedGoogle Scholar
• Smith D, Perry JD, Laine L, et al. Comparison of BD GeneOhm real-time polymerase chain reaction with chromogenic and conventional culture methods for detection of group B Streptococcus in clinical samples. Diagn Microbiol Infect Dis 2008;61:369–72
   PubMedGoogle Scholar
• Alfa MJ, Sepehri S, De Gagne P, et al. Real-time PCR assay provides reliable assessment of intrapartum carriage of group B Streptococcus. J Clin Microbiol 2010;48:3095–9
   PubMed Web of Science ®Google Scholar
• Park JS, Cho DH, Yang JH, et al. Usefulness of a rapid real-time PCR assay in prenatal screening for group B streptococcus colonization. Ann Lab Med 2013;33:39–44
   PubMed Web of Science ®Google Scholar
• Abdelazim IA. Intrapartum polymerase chain reaction for detection of group B streptococcus colonisation. Aust N Z J Obstet Gynaecol 2013;53:236–42
   PubMed Web of Science ®Google Scholar
• Daniels J, Gray J, Pattison H, et al. Intrapartum tests for group B streptococcus: accuracy and acceptability of screening. BJOG 2011;118:257–65
   PubMed Web of Science ®Google Scholar
• Kaambwa B, Bryan S, Gray J, et al. Cost-effectiveness of rapid tests and other existing strategies for screening and management of early-onset group B streptococcus during labor. Br J Obstet Gynecol 2010;117:1616–27
   Google Scholar
• Bourgeois-Nicolaos N, Cordier AG, Guillet-Caruba C, et al. Evaluation of the Cepheid Xpert GBS assay for rapid detection of group B Streptococci in amniotic fluids from pregnant women with premature rupture of membranes. J Clin Microbiol 2013;51:1305–6
   PubMed Web of Science ®Google Scholar
• Langhendries JP. Early bacterial colonisation of the intestine: why it matters? Arch Pediatr 2006;13:1526–34
   PubMedGoogle Scholar
• Romero R, Korzeniewski SJ. Are infants born by elective cesarean delivery without labor at risk for developing immune disorders later in life? Am J Obstet Gynecol 2013;208:243–6
   PubMed Web of Science ®Google Scholar
• Lorquet S, Melin P, Minon JM, et al. Group B streptococcus in the antenatal clinic and in the delivery room: a matter of systematic attitude. J Gynecol Obstet Biol Reprod 2005;34:115–27
   PubMedGoogle Scholar
• Håkansson S, Källén K. Impact and risk factors for early-onset group B streptococcal morbidity: analysis of a national, population-based cohort in Sweden 1997–2001. BJOG 2006;113:1452–8
   PubMed Web of Science ®Google Scholar
• Telford JL, Barocchi MA, Margarit I, et al. Pili in Gram-positive pathogens. Nature Rev Microbiol 2006;4:509–19
   PubMed Web of Science ®Google Scholar
• Margarit I, Rinaudo CD, Galeotti CL, et al. Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. J Infect Dis 2009;199:108–15
   PubMed Web of Science ®Google Scholar
• Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000;342:15–20
   PubMed Web of Science ®Google Scholar
• Kenyon S, Pike K, Jones DR, et al. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labor: 7-year follow-up of the ORACLE II trial. Lancet 2008;372:1319–27
   PubMed Web of Science ®Google Scholar
• Fossieck B, Parker RH. Neurotoxicity during intravenous infusion of penicillin. A review. J Clin Pharmacol 1974;14:504–12
   PubMed Web of Science ®Google Scholar
• Bloom SL, Cox SM, Bawdon RE, Gilstrap LC. Ampicillin for neonatal group B streptococcal prophylaxis: how rapidly can bactericidal concentrations be achieved? Am J Obstet Gynecol 1996;175:974–6
   PubMed Web of Science ®Google Scholar
• Chow KM, Hui AC, Szeto CC. Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside. Eur J Clin Microbiol Infect Dis 2005;24:649–53
   PubMed Web of Science ®Google Scholar
• Colombo DF, Lew JL, Pedersen CA, et al. Optimal timing of ampicillin administration to pregnant women for establishing bactericidal levels in the prophylaxis of group B Streptococcus. Am J Obstet Gynecol 2006;194:466–70
   PubMed Web of Science ®Google Scholar
• Bray RE, Boe RW, Johnson WL. Transfer of ampicillin into fetus and amniotic fluid from maternal plasma in late pregnancy. Am J Obstet Gynecol 1966;96:938–42
   PubMed Web of Science ®Google Scholar
• Fiore Mitchell T, Pearlman MD, Chapman RL, et al. Maternal and transplacental pharmacokinetics of cefazolin. Obstet Gynecol 2001;98:1075–9
   PubMed Web of Science ®Google Scholar
• Popovic J, Grujic Z, Sabo A. Influence of pregnancy on ceftriaxone, cefazolin and gentamicin pharmacokinetics in caesarean vs non pregnant sectioned women. J Clin Pharm Ther 2007;32:595–602
   PubMed Web of Science ®Google Scholar
• Allegaert K, Van Mieghem T, Verbesselt R, et al. Cefazolin pharmacokinetics in maternal plasma and amniotic fluid during pregnancy. Am J Obstet Gynecol 2009;200:170 e1–7
   Google Scholar
• de Cueto M, Sanchez MJ, Sampedro A, et al. Timing of intrapartum ampicillin and prevention of vertical transmission of group B Streptococcus. Obstet Gynecol 1998;91:112–14
   PubMed Web of Science ®Google Scholar
• Lin FY, Brenner RA, Johnson YR, et al. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. Am J Obstet Gynecol 2001;184:1204–10
   PubMed Web of Science ®Google Scholar
• Illuzzi JL, Bracken MB. Duration of intrapartum prophylaxis for neonatal group B streptococcal disease: a systematic review. Obstet Gynecol 2006;108:1254–65
   PubMed Web of Science ®Google Scholar
• Barber EL, Zhao G, Buhimschi IA, Illuzzi JL. Duration of intrapartum prophylaxis and concentration of penicillin G in fetal serum at delivery. Obstet Gynecol 2008;112:265–70
   PubMed Web of Science ®Google Scholar
• Berardi A, Rossi C, Biasini A, et al. Efficacy of intrapartum prophylaxis less than 4 hours duration. J Matern Fetal Neonatal Med 2011;24:619–25
   PubMed Web of Science ®Google Scholar
• Ramus R, McIntire D, Wendell GJ. Antibiotic chemoprophylaxis for group B strep is not necessary with elective cesarean section at term [Abstract]. Am J Obstet Gynecol 1999;180(Suppl):85
   Google Scholar
• Poncelet-Jasserand E, Forges F, Varlet M-N, et al. Reduction of the use of antimicrobial drugs following the rapid detection of Streptococcus agalactiae in the vagina at delivery by real-time PCR assay. BJOG 2013;120:1098–108
   Google Scholar